- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f71e500-170c-4662-8412-0dc754e91f3b - Date
11/26/2013 - Company Name
Ancera - Mailing Address
21 Business Park Drive Branford, CT 06405 - Company Description
The company is developing a rapid, portable technology platform for the separation, quantitative detection and identification of minute concentrations of various pathogens from whole blood or other bodily fluids. Ancera’s platform is based on technology it is licensing exclusively from Yale University. The technology uses magnetic fields to manipulate biologic cells via a ferromagnetic fluid. - Website
http://www.anceradx.com - Transaction Type
Debt - Transaction Amount
$1,277,500 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable. - M&A Terms
- Venture Investor
Undisclosed